Skip to main content Skip to navigation

What Is Terbinafine? Uses, Dosage, Side Effect

What Is Terbinafine?/Terbinafine is a synthetic allylamine derivative with antifungal activity. Terbinafine exerts its effect through inhibition of squalene epoxidase, thereby blocking the biosynthesis of ergosterol, an important component of fungal cell membranes. As a result, this agent disrupts fungal cell membrane synthesis and inhibits fungal growth. Terbinafine is an Allylamine Antifungal. The chemical classification of terbinafine is Allylamine.

Terbinafine is an orally and topically active allylamine fungicidal agent which is used to treat superficial fungal infections of the skin and nails. Terbinafine has been clearly linked to rare instances of acute liver injury that can be severe and sometimes fatal.

Mechanism of Action of Terbinafine

Terbinafine is hypothesized to act by inhibiting squalene monooxygenase, thus blocking the biosynthesis of ergosterol, an essential component of fungal cell membranes. This inhibition also results in an accumulation of squalene, which is a substrate catalyzed to 2,3-oxy do squalene by squalene monooxygenase. The resultant high concentration of squalene and decreased amount of ergosterol are both thought to contribute to terbinafine’s antifungal activity.

Terbinafine hydrochloride (Lamisil) is a synthetic allylamine antifungal. It is highly lipophilic in nature and tends to accumulate in the skin, nails, and fatty tissues. Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase (squalene 2, 3-epoxidase), an enzyme that is part of the fungal cell wall synthesis pathway.

Indications of Terbinafine

  • For the treatment of dermatophyte infections of the toenail or fingernail caused by susceptible fungi. Also for the treatment of tinea capitis (scalp ringworm) and tinea corporis (body ringworm) or tinea cruris (jock itch).
  • Treatment of onychomycosis
  • Terbinafine hydrochloride is indicated to treat fungal skin and nail infections caused by Trichophyton species, Microsporum canisEpidermophyton floccosum,[rx] and Tinea species.[rx] Terbinafine hydrochloride also treats yeast infections of the skin caused by Candida species and Malassezia furfur.12
  • Onychomycosis, Toenail
  • Tinea Capitis
  • Cutaneous Candidiasis
  • Onychomycosis, Fingernail
  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis

Associated Conditions

  • Candidiasis, Cutaneous
  • Onychomycosis
  • Pityriasis Versicolor
  • Sporotrichosis
  • Tinea Capitis
  • Tinea Corporis
  • Tinea Cruris
  • Tinea Pedis
  • Severe Tinea Corporis
  • Severe Tinea Cruris
  • Severe Tinea Pedis

Contraindication of Terbinafine

  • Depression
  • Liver problems
  • Systemic lupus erythematosus
  • An autoimmune disease
  • Abnormal liver function tests
  • A significant drop in a certain type of white blood cell called a neutrophil
  • Allergies to Terbinafine Terbinafine/Butenafine

Dosage of Terbinafine

Strengths: 250 mg; 125 mg; 187.5 mg

Onychomycosis – Fingernail

  • Tablets: 250 mg orally once a day

Duration of therapy

  • Fingernail onychomycosis: 6 weeks
  • Toenail onychomycosis: 12 weeks

Onychomycosis – Toenail

  • Tablets: 250 mg orally once a day

Duration of therapy

  • Fingernail onychomycosis: 6 weeks
  • Toenail onychomycosis: 12 weeks

Tinea Capitis

  • Oral granules: 250 mg orally once a day for 6 weeks

Tinea Corporis

  • Tablets: 250 mg orally once a day for 2 to 4 weeks

Tinea Cruris

  • Some experts recommend: Tablets: 250 mg orally once a day for 2 to 4 weeks

Tinea Pedis

  • Some experts recommend: Tablets: 250 mg orally once a day for 2 to 6 weeks

Pediatric Dose for Tinea Capitis

4 years or older: Oral granules:

  • Less than 25 kg: 125 mg orally once a day
  • 25 to 35 kg: 187.5 mg orally once a day
  • Greater than 35 kg: 250 mg orally once a day
  • Duration of therapy: 6 weeks

For Children, Some Experts Recommend:

  • Tablets: 5 mg/kg/day orally

Based on weight

  • 10 to 20 kg: 62.5 mg orally once a day
  • 21 to 40 kg: 125 mg orally once a day
  • 41 kg or more: 250 mg orally once a day

Duration of therapy

  • Trichophyton tonsurans infection: 2 to 4 weeks
  • Microsporum can is infection: Longer duration needed.S

Side  Effects of Terbinafine

The Most Common

  • signs of anemia (low red blood cells; e.g., dizziness,  pale skin, unusual tiredness or weakness, shortness of breath)
  • signs of depression (e.g., poor concentration, changes in weight, changes in sleep, decreased interest in activities, thoughts of suicide)
  • signs of muscle breakdown (e.g., discolored urine, unexpected muscle pain, aches)
  • skin rash or itching
  • symptoms of blood disorders (such as sore throat, fever, chills, mouth sores, or unusual bleeding or bruising)
  • symptoms of liver problems (such as unusual fatigue, yellow eyes or skin, abdominal pain, dark urine, pale stools, itching, or loss of appetite)
  • vision changes
  • weight loss
  • signs of pancreatitis (e.g., abdominal pain on the upper left side, back pain, nausea, fever, chills, rapid heartbeat, swollen abdomen)
  • symptoms of a serious allergic reaction (such as hives, difficulty breathing, or swelling of the face or throat)
  • symptoms of a serious skin rash (such as redness, blistering, peeling, or loosening of skin)
  • bloating or feeling of fullness in the stomach
  • diarrhea
  • headache
  • heartburn
  • increased sensitivity to the sun
  • loss of appetite
  • nausea
  • stomach pain (mild)


Common

  • indigestion
  • inflammation of the joints
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • light-colored stools
  • lower back or side pain
  • muscle aches
  • painful or difficult urination
  • pains in the stomach, side, or abdomen, possibly radiating to the back
  • persistent loss of appetite
  • pinpoint red spots on the skin
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • red skin lesions, often with a purple center
  • red, irritated eyes
  • red, scaling, or crusted skin
  • sores, ulcers, or white spots on the lips or in the mouth
  • sores, welting, or blisters
  • stomach pain, continuing
  • swollen glands
  • swollen lymph glands
  • tightness in the chest
  • troubled breathing with exertion
  • ulcers, sores, or white spots in the mouth
  • unexplained bleeding or bruising

Rare

  • burning
  • dryness
  • flaking or peeling skin
  • itching
  • other signs of skin irritation not present before use of this medication
  • peeling
  • rash
  • redness
  • scabs
  • skin discoloration
  • skin lesions
  • stinging
  • tingling
  • Body aches or pain
  • diarrhea
  • difficulty with breathing
  • ear congestion
  • a general feeling of discomfort or illness
  • headache
  • joint pain
  • loss of appetite
  • loss of voice
  • nasal congestion
  • nausea
  • runny nose
  • shivering
  • skin rash or itching
  • sneezing
  • sore throat
  • sweating
  • trouble with sleeping
  • Drug

Drug Interactions of Terbinafine

There may be an interaction between terbinafine and any of the following:

  • amiodarone
  • antipsychotic medications (e.g., chlorpromazine, clozapine, haloperidol, olanzapine, quetiapine, risperidone)
  • atomoxetine
  • azole antifungals (e.g., fluconazole, itraconazole, ketoconazole)
  • beta-adrenergic blockers (e.g., atenolol, propranolol, sotalol)
  • birth control pills
  • caffeine and products that contain caffeine
  • captopril
  • carbamazepine
  • carvedilol
  • chloroquine
  • chlorpheniramine
  • cimetidine
  • codeine
  • cyclosporine
  • dextromethorphan
  • doxepin
  • doxorubicin
  • fesoterodine
  • flecainide
  • MAO inhibitors type B (e.g., maprotiline, selegiline)
  • mercaptopurine
  • methamphetamine
  • mexiletine
  • mirtazapine
  • nefazodone
  • oxycodone
  • phenobarbital
  • phenytoin
  • pimozide
  • primaquine
  • primidone
  • procainamide
  • propafenone
  • rifabutin
  • rifampin
  • Saccharomyces boulardii
  • selective serotonin reuptake inhibitors (SSRIs; e.g., citalopram, fluoxetine, paroxetine, sertraline)
  • tamoxifen
  • tamsulosin
  • tetrabenazine
  • theophylline
  • tolbutamide
  • tolterodine
  • tramadol
  • triazolam
  • tricyclic antidepressants (e.g., amitriptyline, desipramine)
  • venlafaxine
  • warfarin

Pregnancy Category of Terbinafine

FDA Pregnancy Category B

Pregnancy

This medication should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medication, contact your doctor immediately.

Breast-feeding

This medication passes into breast milk. If you are a breast-feeding mother and are taking terbinafine, it may affect your baby. Women taking terbinafine tablets should not breast-feed. If you are using the cream or spray, talk to your doctor about whether you should continue breast-feeding. The safety and effectiveness of using this medication have not been established for children.


References

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

References

Add references, clinical guidelines, textbooks, journal articles, or trusted medical sources here. You can edit this area later with a custom field named _rx_references.

Written by Dr. Harun Ar Rashid, MD - Arthritis, Bones, Joints Pain, Trauma, and Internal Medicine Specialist

Dr. Md. Harun Ar Rashid, MPH, MD, PhD, is a highly respected medical specialist celebrated for his exceptional clinical expertise and unwavering commitment to patient care. With advanced qualifications including MPH, MD, and PhD, he integrates cutting-edge research with a compassionate approach to medicine, ensuring that every patient receives personalized and effective treatment. His extensive training and hands-on experience enable him to diagnose complex conditions accurately and develop innovative treatment strategies tailored to individual needs. In addition to his clinical practice, Dr. Harun Ar Rashid is dedicated to medical education and research, writing and inventory creative thinking, innovative idea, critical care managementing make in his community to outreach, often participating in initiatives that promote health awareness and advance medical knowledge. His career is a testament to the high standards represented by his credentials, and he continues to contribute significantly to his field, driving improvements in both patient outcomes and healthcare practices. Born and educated in Bangladesh, Dr. Rashid earned his BPT from the University of Dhaka before pursuing postgraduate training internationally. He completed his MD in Internal Medicine at King’s College London, where he developed a special interest in inflammatory arthritis and metabolic bone disease. He then undertook a PhD in Orthopedic Science at the University of Oxford, conducting pioneering research on cytokine signaling pathways in rheumatoid arthritis. Following his doctoral studies, Dr. Rashid returned to clinical work with a fellowship in interventional pain management at the Rx University School of Medicine, refining his skills in image-guided joint injections and minimally invasive pain-relief techniques.